32172343|t|Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.
32172343|a|Parkinson's disease (PD) is a progressive neurodegenerative brain disease presenting with a variety of motor and non-motor symptoms, loss of midbrain dopaminergic neurons in the substantia nigra pars compacta and the occurrence of alpha-synuclein-positive Lewy bodies in surviving neurons. Here, we performed whole exome sequencing in 52 early-onset PD patients and identified 3 carriers of compound heterozygous mutations in the ATP10B P4-type ATPase gene. Genetic screening of a Belgian PD and dementia with Lewy bodies (DLB) cohort identified 4 additional compound heterozygous mutation carriers (6/617 PD patients, 0.97%; 1/226 DLB patients, 0.44%). We established that ATP10B encodes a late endo-lysosomal lipid flippase that translocates the lipids glucosylceramide (GluCer) and phosphatidylcholine (PC) towards the cytosolic membrane leaflet. The PD associated ATP10B mutants are catalytically inactive and fail to provide cellular protection against the environmental PD risk factors rotenone and manganese. In isolated cortical neurons, loss of ATP10B leads to general lysosomal dysfunction and cell death. Impaired lysosomal functionality and integrity is well known to be implicated in PD pathology and linked to multiple causal PD genes and genetic risk factors. Our results indicate that recessive loss of function mutations in ATP10B increase risk for PD by disturbed lysosomal export of GluCer and PC. Both ATP10B and glucocerebrosidase 1, encoded by the PD risk gene GBA1, reduce lysosomal GluCer levels, emerging lysosomal GluCer accumulation as a potential PD driver.
32172343	8	14	ATP10B	Gene	23120
32172343	25	44	Parkinson's disease	Disease	MESH:D010300
32172343	76	92	glucosylceramide	Chemical	MESH:D005963
32172343	101	120	Parkinson's disease	Disease	MESH:D010300
32172343	122	124	PD	Disease	MESH:D010300
32172343	143	174	neurodegenerative brain disease	Disease	MESH:D019636
32172343	332	347	alpha-synuclein	Gene	6622
32172343	451	453	PD	Disease	MESH:D010300
32172343	454	462	patients	Species	9606
32172343	590	592	PD	Disease	MESH:D010300
32172343	597	622	dementia with Lewy bodies	Disease	MESH:D020961
32172343	624	627	DLB	Disease	MESH:D020961
32172343	707	709	PD	Disease	MESH:D010300
32172343	710	718	patients	Species	9606
32172343	733	736	DLB	Disease	MESH:D020961
32172343	737	745	patients	Species	9606
32172343	775	781	ATP10B	Gene	23120
32172343	856	872	glucosylceramide	Chemical	MESH:D005963
32172343	874	880	GluCer	Chemical	MESH:D005963
32172343	886	905	phosphatidylcholine	Chemical	MESH:D010713
32172343	907	909	PC	Chemical	MESH:D010713
32172343	955	957	PD	Disease	MESH:D010300
32172343	969	975	ATP10B	Gene	23120
32172343	1077	1079	PD	Disease	MESH:D010300
32172343	1093	1101	rotenone	Chemical	MESH:D012402
32172343	1106	1115	manganese	Chemical	MESH:D008345
32172343	1155	1161	ATP10B	Gene	23120
32172343	1179	1200	lysosomal dysfunction	Disease	MESH:D016464
32172343	1298	1300	PD	Disease	MESH:D010300
32172343	1341	1343	PD	Disease	MESH:D010300
32172343	1442	1448	ATP10B	Gene	23120
32172343	1467	1469	PD	Disease	MESH:D010300
32172343	1503	1509	GluCer	Chemical	MESH:D005963
32172343	1514	1516	PC	Chemical	MESH:D010713
32172343	1523	1529	ATP10B	Gene	23120
32172343	1571	1573	PD	Disease	MESH:D010300
32172343	1584	1588	GBA1	Gene	2629
32172343	1607	1613	GluCer	Chemical	MESH:D005963
32172343	1641	1647	GluCer	Chemical	MESH:D005963
32172343	1676	1678	PD	Disease	MESH:D010300
32172343	Association	MESH:D010300	23120
32172343	Association	MESH:D005963	MESH:D010300
32172343	Association	MESH:D016464	23120
32172343	Association	MESH:D010300	2629
32172343	Positive_Correlation	MESH:D012402	MESH:D010300
32172343	Association	MESH:D008345	MESH:D010300
32172343	Association	MESH:D010713	MESH:D010300
32172343	Association	MESH:D020961	23120
32172343	Association	MESH:D005963	23120
32172343	Negative_Correlation	MESH:D005963	2629
32172343	Association	MESH:D010713	23120

